Quorum Review IRB Establishes an East Coast Ethics Board Focused on Oncology
Quorum Review IRB
is introducing a new ethics board located in Cambridge, Massachusetts. This panel includes members from academia with significant expertise in oncology research. The Cambridge Board will begin reviewing studies on October 4, 2011. Quorum will continue to hold eight board meetings each week.
Oncology is a complex, fast-moving, and innovative area of clinical research. With this panel, researchers can benefit from IRB members with years of experience in oncology treatment and research. Quorum’s broad range of therapeutic expertise will also be supported as members are affiliated with a range of institutions, including Harvard Medical School, Dana Farber, Tufts, and Boston University.
The Cambridge Board will meet weekly. Researchers may also submit oncology studies to the next available Board meeting, as Quorum always includes oncology expertise on a panel when a cancer study is presented for review.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025